Skip to main content
HLB PHARMACEUTICAL CO., LTD. logo

HLB PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 047920 ISIN · KR7047920004 KO Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2024-06-24 Major Shareholding Noti…
Country KR South Korea
Listing KO 047920

About HLB PHARMACEUTICAL CO., LTD.

https://www.hlbpharma.co.kr/eng/

HLB PHARMACEUTICAL CO., LTD. is a biopharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in the production of quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices. Its portfolio also includes prescription medications like skeletal muscle relaxants. A key focus of its research and development activities is the discovery and advancement of new peptide-based drugs. As part of the broader HLB Group, it contributes to a diverse portfolio that spans pharmaceuticals, medical devices, and diagnostics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding the pledging of shares by the major shareholder (HLB Life Science) for financing purposes. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership stakes and changes in control-related holdings.
2024-06-24 Korean
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to the company (HLB Pharmaceutical) regarding 'significant market fluctuations' (현저한 시황변동). This is a standard regulatory inquiry requiring a response by a specific deadline. Since it is a regulatory communication that does not fit into specific categories like financial reports or shareholder notices, it falls under the general regulatory filing category.
2024-05-20 Korean
기타경영사항(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure (자율공시) from HLB Pharmaceutical in response to a request for clarification regarding significant market fluctuations. It details the receipt of a Complete Response Letter (CRL) from the FDA concerning a drug approval process. Since this is a formal regulatory announcement regarding company operations and market disclosures that does not fit into specific categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2024-05-20 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HLB Pharmaceutical Co., Ltd. covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial data, business operations, and management information, which is characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself. Q1 2024
2024-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity or individual crosses a significant ownership threshold (typically 5%) in a listed company. This document details the shareholding status, changes in ownership, and purpose of holding (management influence) for HLB Life Science regarding HLB Pharmaceutical. This falls under the 'Major Shareholding Notification' category.
2024-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, election of directors and auditors, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the outcome of shareholder votes.
2024-03-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.